CD138 Negative Plasmablastic Lymphoma: A Diagnostic Pitfall

被引:0
|
作者
Wang, Yi [1 ]
Pan, Zenggang [2 ]
Yuan, Ji [3 ]
Chen, Mingyi [4 ]
Zhao, Chen [5 ]
Wang, Yanhua
Shi, Yang
Wu, Xiaojun [6 ]
Zheng, Gang [6 ]
机构
[1] Montefiore Med Ctr, Stony Brook, NY USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Univ Nebraska Med Ctr, Omaha, NE USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Iowa, Iowa City, IA USA
[6] Johns Hopkins Sch Med, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1413
引用
收藏
页数:1
相关论文
共 50 条
  • [21] CD38 and CD138 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Kampalath, B
    Novoa-Takara, L
    Rao, N
    Shidham, VB
    Chang, CC
    MODERN PATHOLOGY, 2003, 16 (01) : 238A - 238A
  • [22] Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma
    Ahn, Janice S.
    Okal, Ryan
    Vos, Jeffrey A.
    Smolkin, Matthew
    Kanate, Abraham S.
    Rosado, Flavia G.
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (09) : 775 - 780
  • [23] Molecular cloning and expression analysis of pig CD138
    Bae, Joonbeom
    Jeong, Seonah
    Lee, Ju Yeon
    Lee, Hyun-Jeong
    Choi, Bong-Hwan
    Kim, Ji-Eun
    Choi, Inho
    Chun, Taehoon
    RESEARCH IN VETERINARY SCIENCE, 2013, 95 (03) : 1021 - 1025
  • [24] CD138 as a Specific CSF Biomarker of Multiple Sclerosis
    Hinsinger, Geoffrey
    De Terdonck, Lucile Du Trieu
    Urbach, Serge
    Salvetat, Nicolas
    Rival, Manon
    Galoppin, Manon
    Ripoll, Chantal
    Cezar, Renaud
    Laurent-Chabalier, Sabine
    Demattei, Christophe
    Agherbi, Hanane
    Castelnovo, Giovanni
    Lehmann, Sylvain
    Rigau, Valerie
    Marin, Philippe
    Thouvenot, Eric
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (03): : e200230
  • [25] Syndecan-1 (CD138), Carcinomas and EMT
    Couchman, John R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [26] The significance of soluble CD138 in diagnosis of monoclonal gammopathies
    Maisnar, V
    Tousková, M
    Tichy, M
    Krejsek, J
    Chrobák, L
    Voglová, J
    Maly, J
    NEOPLASMA, 2006, 53 (01) : 26 - 29
  • [27] Plasmablastic Lymphoma in a HIV Negative Patient
    Zahid, M.
    Deemer, E.
    Mishra, S.
    Mehta, S.
    Mezinord, A.
    Morales, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 238 - 239
  • [28] Significance of CXCL12-CXCR7 Signaling for CD20(-)CD138(-) Subpopulation in Lymphoplasmacytic Lymphoma
    Wada, N. W.
    Ikeda, J. I.
    Nojima, S. N.
    Tahara, S. T.
    Ohshima, K. O.
    Okuzaki, D. O.
    Morii, E. M.
    JOURNAL OF PATHOLOGY, 2016, 240 : 44 - 44
  • [29] CD20-Negative CD138-Positive Leukemic Large Cell Lymphoma with Plasmablastic Differentiation with an IgH/MYC Translocation in an HIV-Positive Patient
    Yotsumoto, Mihoko
    Ichikawa, Naoaki
    Ueno, Mayumi
    Higuchi, Yumiko
    Asano, Naoko
    Kobayashi, Hikaru
    INTERNAL MEDICINE, 2009, 48 (07) : 559 - 562
  • [30] Plasmablastic Lymphoma vs Myeloma With Plasmablastic Morphology: An Ongoing Diagnostic Dilemma
    Ahn, Janice
    Okal, Ryan
    Vos, Jeffrey
    Smolkin, Matthew
    Rosado, Flavia
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A125 - A125